Fifth Third Bancorp
CTSO icon

Fifth Third Bancorp’s Cytosorbents Corp CTSO Stock Holding History

Fifth Third Bancorp’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Buy
3,090
+8
+0.3% +$4 ﹤0.01% 4157
2026
Q1 		$1.75K Buy
+3,082
New +$2.1K ﹤0.01% 4052
2015
Q2 		– Sell
-1,600
Closed -$21K – 2876
2015
Q1 		$21K Buy
+1,600
New +$16.5K ﹤0.01% 1731

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fifth Third Bancorp's CTSO Position: Q2 2026 in Review

Fifth Third Bancorp increased its Cytosorbents Corp (CTSO) stake by 0.26% in Q2 2026, buying an estimated $4 and bringing the position to 3,090 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4157.

Fifth Third Bancorp first reported a position in CTSO in Q1 2015 and has held it in 3 quarters since. The position peaked at $21K in Q1 2015. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Fifth Third Bancorp held 3,090 shares of Cytosorbents Corp worth $1.16K as of Q2 2026.
  • Fifth Third Bancorp bought 8 Cytosorbents Corp shares in Q2 2026, an estimated $4.
  • Cytosorbents Corp made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4157 holding.
  • Fifth Third Bancorp first reported a position in Cytosorbents Corp in Q1 2015 and has held it in 3 quarters since.
  • Fifth Third Bancorp's Cytosorbents Corp position peaked at $21K in Q1 2015.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.